These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2671610)
1. Protective role of human antibody to the fusion protein of measles virus. Sato TA; Kohama T; Sugiura A Microbiol Immunol; 1989; 33(7):601-7. PubMed ID: 2671610 [TBL] [Abstract][Full Text] [Related]
2. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. Varsanyi TM; Morein B; Löve A; Norrby E J Virol; 1987 Dec; 61(12):3896-901. PubMed ID: 2960833 [TBL] [Abstract][Full Text] [Related]
3. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. de Vries P; van Binnendijk RS; van der Marel P; van Wezel AL; Voorma HO; Sundquist B; Uytdehaag FG; Osterhaus AD J Gen Virol; 1988 Mar; 69 ( Pt 3)():549-59. PubMed ID: 3258355 [TBL] [Abstract][Full Text] [Related]
4. A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response. Steward MW; Stanley CM; Obeid OE J Virol; 1995 Dec; 69(12):7668-73. PubMed ID: 7494275 [TBL] [Abstract][Full Text] [Related]
5. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity. Olszewska W; Obeid OE; Steward MW Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752 [TBL] [Abstract][Full Text] [Related]
6. Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection. Atabani SF; Obeid OE; Chargelegue D; Aaby P; Whittle H; Steward MW J Virol; 1997 Oct; 71(10):7240-5. PubMed ID: 9311797 [TBL] [Abstract][Full Text] [Related]
7. Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. Malvoisin E; Wild F J Virol; 1990 Oct; 64(10):5160-2. PubMed ID: 2398539 [TBL] [Abstract][Full Text] [Related]
8. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946 [TBL] [Abstract][Full Text] [Related]
9. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Drillien R; Spehner D; Kirn A; Giraudon P; Buckland R; Wild F; Lecocq JP Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1252-6. PubMed ID: 3422488 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303 [TBL] [Abstract][Full Text] [Related]
12. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. Wild TF; Bernard A; Spehner D; Drillien R J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193 [TBL] [Abstract][Full Text] [Related]
13. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus. Obeid OE; Stanley CM; Steward MW Virus Res; 1996 Jun; 42(1-2):173-80. PubMed ID: 8806185 [TBL] [Abstract][Full Text] [Related]
14. Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents. Fooks AR; Jeevarajah D; Lee J; Warnes A; Niewiesk S; ter Meulen V; Stephenson JR; Clegg JC J Gen Virol; 1998 May; 79 ( Pt 5)():1027-31. PubMed ID: 9603317 [TBL] [Abstract][Full Text] [Related]
15. The molecular basis of the antigenic cross-reactivity between measles and cowpea mosaic viruses. Olszewska W; Steward MW Virology; 2003 May; 310(1):183-9. PubMed ID: 12788642 [TBL] [Abstract][Full Text] [Related]
17. The sensitivity of measles virus haemolysin to acetone and the preparation of mono-specific human anti-haemolysin by absorption. Armstrong MA; Fraser KB; Shirodaria PV J Gen Virol; 1979 Aug; 44(2):541-4. PubMed ID: 392051 [TBL] [Abstract][Full Text] [Related]
18. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Giraudon P; Wild TF Virology; 1985 Jul; 144(1):46-58. PubMed ID: 2414919 [TBL] [Abstract][Full Text] [Related]
19. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. de Swart RL; Yüksel S; Osterhaus AD J Virol; 2005 Sep; 79(17):11547-51. PubMed ID: 16103210 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein. Muller CP; Schroeder T; Tu R; Brons NH; Jung G; Schneider F; Wiesmüller KH Scand J Immunol; 1993 Nov; 38(5):463-71. PubMed ID: 7694357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]